Evidence map›Paper›PMID 41388290›Full record

ReviewCancer cell international2025

Cross-talk between cancer-associated fibroblasts and dormant cancer cells: current status and promising therapeutic potential.

Jiayue Liu, Yue Zhang, Kai Liu, Jialong Shi, Man Yan, Jing Xu, Yandi Liu, Shiwu Zhang

Abstract readReview
In one paragraph

Review in Cancer cell international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiayue Liu *School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, P.R. China.
Yue Zhang *Department of Pathology, Tianjin Union Medical Center, Tianjin, 300071, P.R. China.
Kai Liu *Department of Research and Education, Tianjin Beichen Hospital, Tianjin, China.
Jialong ShiSchool of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, P.R. China.
Man YanSchool of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, P.R. China.
Jing XuDepartment of General Surgery, Tianjin Union Medical Center, Nankai University, Tianjin, China.
Yandi LiuDepartment of Gastroenterology, Tianjin Union Medical Center, Tianjin, 300121, China.
Shiwu ZhangDepartment of Pathology, Tianjin Union Medical Center, Tianjin, 300071, P.R. China. zhangshiwu666@aliyun.com.

Funding

Foundation of the committee on science and technology of Tianjin 21JCZDJC00230National Natural Science Foundation of China 82173283
6 · The paper itself

Abstract

Cancer-associated stromal cells, particularly cancer-associated fibroblasts (CAFs), are pivotal components of the tumor microenvironment (TME) that significantly influence cancer progression. Communication between CAFs and cancer cells orchestrates key aspects of tumor dynamics, including the induction of dormancy. In response to adverse environmental stimuli, such as hypoxia, chemotherapy, or radiotherapy, cancer cells enter a dormant state, enabling them to evade environmental stimuli. The duration of this dormancy varies with the type, differentiation degree, and proliferation rate of primary cancer. The process is regulated by CAFs through various mediators, including growth factors, chemokines, inflammatory factors, exosomes, etc. Notably, environmental stimuli can induce the formation of polyploid giant cancer cells (PGCCs), a dormant cell type characterized by high drug resistance, tumorigenicity, and stemness. This review summarizes the relationship between CAFs and cancer cell dormancy, and explores the potential mechanisms through which CAFs regulate this process.

Indexed as

Cancer-associated fibroblastsCancer cell dormancyPolyploid giant cancer cellsTumor microenvironment

Identifiers

PMID41388290
PMCPMC12817440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.